Evidence map›Paper›PMID 32191641›Full record

ArticleThe Journal of clinical investigation2020

c-Rel gain in B cells drives germinal center reactions and autoantibody production.

Maike Kober-Hasslacher, Hyunju Oh-Strauß, Dilip Kumar, Valeria Soberon, Carina Diehl, Maciej Lech, Thomas Engleitner, Eslam Katab, Vanesa Fernández-Sáiz, Guido Piontek and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. HemaSphere · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Transient interactions modulate the affinity of NF-κB transcription factors for DNA.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

Maike Kober-HasslacherInstitute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich, Germany.
Hyunju Oh-StraußInstitute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich, Germany.
Dilip KumarMax Planck Institute of Biochemistry, Martinsried, Germany.
Valeria SoberonInstitute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich, Germany.
Carina DiehlInstitute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich, Germany.
Maciej LechRenal Division, Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany.
Thomas EngleitnerCenter for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
Eslam KatabCenter for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
Vanesa Fernández-SáizCenter for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
Guido PiontekInstitute of Pathology, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany.
Hongwei LiCenter for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
Björn MenzeCenter for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
Christoph ZiegenhainAnthropology and Human Genomics, Department of Biology II, Ludwig-Maximilians-Universität, Martinsried, Germany.
Wolfgang EnardAnthropology and Human Genomics, Department of Biology II, Ludwig-Maximilians-Universität, Martinsried, Germany.
Roland RadCenter for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
Jan P BöttcherInstitute of Molecular Immunology and Experimental Oncology, School of Medicine, Technical University of Munich, Munich, Germany.
Hans-Joachim AndersRenal Division, Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany.
Martina RudeliusInstitute of Pathology, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany.
Marc Schmidt-SupprianInstitute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich, Germany.
Technical University of Munich · DELudwig-Maximilians-Universität München · DEGerman Cancer Research Center · DELMU Klinikum · DEMax Planck Institute of Biochemistry · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-nucleotide polymorphisms and locus amplification link the NF-κB transcription factor c-Rel to human autoimmune diseases and B cell lymphomas, respectively. However, the functional consequences of enhanced c-Rel levels remain enigmatic. Here, we overexpressed c-Rel specifically in mouse B cells from BAC-transgenic gene loci and demonstrate that c-Rel protein levels linearly dictated expansion of germinal center B (GCB) cells and isotype-switched plasma cells. c-Rel expression in B cells of otherwise c-Rel-deficient mice fully rescued terminal B cell differentiation, underscoring its critical B cell-intrinsic roles. Unexpectedly, in GCB cells transcription-independent regulation produced the highest c-Rel protein levels among B cell subsets. In c-Rel-overexpressing GCB cells this caused enhanced nuclear translocation, a profoundly altered transcriptional program, and increased proliferation. Finally, we provide a link between c-Rel gain and autoimmunity by showing that c-Rel overexpression in B cells caused autoantibody production and renal immune complex deposition.

Indexed as

Antibody FormationPolymorphism, Single NucleotideAnimalsAutoantibodiesGerminal CenterMiceMice, TransgenicPlasma CellsProto-Oncogene Proteins c-relAutoantibodiesProto-Oncogene Proteins c-relAutoimmune diseasesAutoimmunityB cellsImmunologyNF-kappaB

Identifiers

PMID32191641
PMCPMC7260018
OpenAlexW3010897554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.